News
“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...
FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the ...
Each year, almost 200,000 adults 65 and older are hospitalized due to RSV, and an estimated 14,000 of those cases result in ...
12h
AllAfrica on MSNGovernment Is Considering Providing a Vaccine to Protect Babies From RSVA new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa's private sector but not yet in public clinics. The country's advisory group on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results